文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

乳腺癌相关重度淋巴水肿发展的风险因素:一项回顾性队列研究。

Risk factors for the development of severe breast cancer-related lymphedema: a retrospective cohort study.

机构信息

General Surgery, Cancer center, Department of Breast Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, 310014, Zhejiang, China.

Department of Breast Surgery, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, 310022, Zhejiang, China.

出版信息

BMC Cancer. 2023 Apr 20;23(1):361. doi: 10.1186/s12885-023-10814-5.


DOI:10.1186/s12885-023-10814-5
PMID:37081431
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10116791/
Abstract

BACKGROUND: Severe lymphedema presents a challenge in terms of treatment due to the significant formation of scar tissue that accompanies it. The aim of this study was to identify intraoperative and preoperative risk factors of severe lymphedema and to develop a nomogram for estimating the risk of severe lymphedema within 3 years of surgery. METHOD: Data was collected from a retrospective cohort of 326 patients with BCRL at the Zhejiang Cancer Hospital from November 2015 to November 2018. Univariate and multivariate logistic regression analysis was conducted to identify predictive indicators of severe lymphedema. A nomogram was developed to further improve the clinical applicability. RESULTS: In the retrospective cohort, the ratio of severe/non-severe lymphedema within 3 years of surgery was 1:3. Independent risk factors for severe lymphedema were determined to be age, positive lymph nodes, interpectoral (Rotter's) lymph nodes (IPNs) dissection, and educational level. IPNs dissection was found to contribute greatly to the development of severe lymphedema with a higher odds ratio (7.76; 95% CI: 3.87-15.54) than other risk factors. A nomogram was developed by integrating age, positive lymph nodes, IPNs dissection, and educational level, which yielded a C-index of 0.810 and 0.681 in the training and validation cohort, respectively. This suggested a moderate performance of the nomogram in predicting the risk of severe lymphedema within 3 years of surgery. The cut-off values of the low-, medium- and high-risk probabilities were 0.0876 and 0.3498, and the severe lymphedema exhibited a significantly higher risk probability as compared with the non-severe lymphedema. CONCLUSION: This study identified the risk factors of severe lymphedema and highlighted the substantial contribution of IPNs dissection to the severity of lymphedema.

摘要

背景:由于严重淋巴水肿伴有大量的疤痕组织形成,治疗极具挑战性。本研究旨在确定术中及术前导致严重淋巴水肿的危险因素,并建立一个预测术后 3 年内发生严重淋巴水肿风险的列线图。

方法:回顾性收集了 2015 年 11 月至 2018 年 11 月在浙江省肿瘤医院接受 BCRL 治疗的 326 例患者的数据。采用单因素和多因素 logistic 回归分析确定严重淋巴水肿的预测指标。并建立了一个列线图,以进一步提高临床适用性。

结果:在回顾性队列中,术后 3 年内严重/非严重淋巴水肿的比例为 1:3。年龄、阳性淋巴结、胸内(Rotter's)淋巴结(IPNs)清扫术和教育水平是严重淋巴水肿的独立危险因素。IPNs 清扫术是导致严重淋巴水肿的主要因素,其比值比(OR)为 7.76(95%CI:3.87-15.54),高于其他危险因素。该研究通过整合年龄、阳性淋巴结、IPNs 清扫术和教育水平,建立了一个列线图,在训练集和验证集中的 C 指数分别为 0.810 和 0.681,表明该列线图在预测术后 3 年内发生严重淋巴水肿的风险方面具有中等性能。低、中、高风险概率的截断值分别为 0.0876 和 0.3498,与非严重淋巴水肿相比,严重淋巴水肿的风险概率显著更高。

结论:本研究确定了严重淋巴水肿的危险因素,并强调了 IPNs 清扫术对淋巴水肿严重程度的重要贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/decb/10116791/d123e685d429/12885_2023_10814_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/decb/10116791/644baec91cf8/12885_2023_10814_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/decb/10116791/d123e685d429/12885_2023_10814_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/decb/10116791/644baec91cf8/12885_2023_10814_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/decb/10116791/d123e685d429/12885_2023_10814_Figa_HTML.jpg

相似文献

[1]
Risk factors for the development of severe breast cancer-related lymphedema: a retrospective cohort study.

BMC Cancer. 2023-4-20

[2]
Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.

Breast Cancer Res Treat. 2024-4

[3]
Analysis of the Risk Factors of Breast Cancer-Related Lymphedema and Construction and Evaluation of a Prediction Model.

Lymphat Res Biol. 2023-12

[4]
Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.

Breast Cancer. 2020-9

[5]
The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.

Breast. 2023-4

[6]
Time trend of breast cancer-related lymphedema according to body mass index.

Eur J Surg Oncol. 2024-6

[7]
Development and Validation of a Risk Model for Breast Cancer-Related Lymphedema.

JAMA Netw Open. 2020-11-2

[8]
The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.

Breast Cancer. 2018-2-3

[9]
Impact of risk factors, early rehabilitation and management of lymphedema associated with breast cancer: a retrospective study of breast Cancer survivors over 5 years.

BMC Womens Health. 2024-4-6

[10]
Body mass index increases the risk of breast cancer-related lymphedema at 6-18 months after surgery: a retrospective study.

Support Care Cancer. 2023-4-19

引用本文的文献

[1]
Development and validation of a predictive nomogram for postoperative upper limb lymphedema in breast cancer patients: a retrospective cohort study.

Sci Rep. 2025-7-9

[2]
Risk factors for severity of breast cancer-related lymphedema.

Radiat Oncol. 2025-5-20

[3]
Commonly Prescribed Chronic Pharmacological Medications as Risk Factors for Breast Cancer-Related Lymphedema: An Observational Retrospective Cohort Study.

Healthcare (Basel). 2025-3-21

[4]
Research trends on lymphedema after mastectomy for breast cancer patients from 2000 to 2023: a scientometric analysis.

Front Oncol. 2025-2-4

[5]
The prognostic effect and mechanism of erysipelas in cancer-associated lymphedema.

Sci Rep. 2025-2-14

[6]
Predictive models for breast cancer-related lymphedema after mastectomy.

Am J Transl Res. 2024-9-15

[7]
Contemporaneous Symptom Networks of Breast Cancer-Related Upper Limb Lymphedema: A Network Analysis.

Ann Surg Oncol. 2024-10

本文引用的文献

[1]
Risk factors for arm lymphedema following breast cancer surgery: a Japanese nationwide database study of 84,022 patients.

Breast Cancer. 2023-1

[2]
Interpectoral Lymph Node Dissection Can Be Spared in pN0/N1 Invasive Breast Cancer Undergoing Modified Radical Mastectomy: Single-Institution Experience from Mainland China.

Cancer Manag Res. 2021-7-27

[3]
Model-Based Patterns of Lymphedema Symptomatology: Phenotypic and Biomarker Characterization.

Curr Breast Cancer Rep. 2021-3

[4]
Correlation of older age with severity of lymphedema in breast cancer survivors: A systematic review.

Breast Dis. 2021

[5]
Development and validation of a nomogram to predict the risk of breast cancer-related lymphedema among Chinese breast cancer survivors.

Support Care Cancer. 2021-9

[6]
Breast Cancer-Related Lymphedema: Risk Factors, Screening, Management, and the Impact of Locoregional Treatment.

J Clin Oncol. 2020-7-10

[7]
Body Mass Index as a Major Risk Factor for Severe Breast Cancer-Related Lymphedema.

Lymphat Res Biol. 2020-12

[8]
Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.

Breast Cancer. 2020-9

[9]
Pathophysiology of aged lymphatic vessels.

Aging (Albany NY). 2019-8-28

[10]
Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective.

Ann Surg. 2021-7-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索